TRIM33 and myositis disease: Third, we identified TIF1γ as a target for multiple myositis-specific autoantibodies, with anti-Mi2 autoantibodies recognizing the PHD finger in the C-terminus of TIF1γ, while anti-TIF1γ autoantibodies primarily bind to the N-terminal region.